title: Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study.
abstract: Fibulin-1 (FBLN1) is involved in the progression of some types of cancer. However, the role of FBLN1 in colorectal cancer (CRC) has not been examined. The purpose of this study was to understand the molecular mechanisms and clinical significance of FBLN1 inactivation in CRC. The expression of FBLN1 in CRC tissues and adjacent normal tissues was analyzed by immunohistochemical analysis and quantitative real-time polymerase chain reaction (qRT-PCR). Methylation-specific polymerase chain reaction (MSP) and bisulfite sequencing PCR (BSP) were performed to examine the methylation status of the FBLN1 gene promoter. Furthermore, the methylated level of FBLN1 was analyzed with the clinicopathological characteristics. Immunohistochemical analysis and qRT-PCR analysis showed that FBLN1 protein and messenger RNA (mRNA) levels in tumor tissues were both significantly decreased compared with that in adjacent nontumor tissues. The methylation rate of FBLN1 promoter was significantly higher in CRC tissues than that in adjacent nontumor tissues (P < 0.001). In addition, the correlation between FBLN1 hypermethylation, protein expression, and overall survival (OS) was statistically significant. Our results indicated that the FBLN1 gene may be a novel candidate of tumor suppressor gene in CRC, and that promoter hypermethylation of FBLN1 is an important reason for its downregulation and is also a good predictor of OS for CRC.
authors.affiliation: From the Department of Gastroenterology (ZX, DL, JH), 2nd Xiangya Hospital, Central South University, Changsha, Hunan; and Department of Gastroenterology (ZX, HC), People's Hospital of Taizhou, Taizhou, Jiangsu, China.
authors.forename: Zhiying
authors.initials: Z
authors.lastname: Xu
authors.forename: Hui
authors.initials: H
authors.lastname: Chen
authors.forename: Deliang
authors.initials: D
authors.lastname: Liu
authors.forename: Jirong
authors.initials: J
authors.lastname: Huo
mesh_terms: D002135:Calcium-Binding Proteins / Q000378:metabolism*; D015179:Colorectal Neoplasms / Q000235:genetics*; D019175:DNA Methylation / Q000502:physiology*; D015536:Down-Regulation / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011401:Promoter Regions, Genetic / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism
chemical_list: D002135:Calcium-Binding Proteins; D012333:RNA, Messenger; C060820:fibulin
references.citation: Nat Rev Mol Cell Biol. 2003 Jun;4(6):479-89
references.pmid: 12778127
references.citation: Tumour Biol. 2014 Jan;35(1):123-7
references.pmid: 23907575
references.citation: J Biol Chem. 2007 Apr 20;282(16):11805-16
references.pmid: 17324935
references.citation: Cancer Res. 2007 May 1;67(9):4271-7
references.pmid: 17483339
references.citation: N Engl J Med. 2008 Mar 13;358(11):1148-59
references.pmid: 18337604
references.citation: Clin Exp Metastasis. 2008;25(4):377-88
references.pmid: 17972146
references.citation: Gastroenterology. 2008 Oct;135(4):1079-99
references.pmid: 18773902
references.citation: Epigenetics. 2008 Sep;3(5):270-80
references.pmid: 19001875
references.citation: Br J Cancer. 2008 Dec 16;99(12):2083-7
references.pmid: 18985039
references.citation: Semin Cancer Biol. 2009 Jun;19(3):188-97
references.pmid: 19429483
references.citation: Tumori. 2010 Nov-Dec;96(6):889-901
references.pmid: 21388049
references.citation: Mol Carcinog. 2011 Aug;50(8):571-9
references.pmid: 21268132
references.citation: Curr Opin Genet Dev. 2012 Feb;22(1):50-5
references.pmid: 22402447
references.citation: J Urol. 2013 Jul;190(1):291-301
references.pmid: 23391467
references.citation: J Gastroenterol Hepatol. 2005 Dec;20(12):1920-6
references.pmid: 16336454